Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a qrs complex ≥120 milliseconds

Circulation

Volumn 124, Issue 25, 2011, Pages 2874-2881

  Thibault, Bernard ^a   Ducharme, Anique ^a   Harel, François ^a   White, Michel ^a   Omeara, Eileen ^a   Guertin, Marie Claude ^a   Lavoie, Joel ^a   Frasure Smith, Nancy ^b   Dubuc, Marc ^a   Guerra, Peter ^a   MacLe, Laurent ^a   Rivard, Léna ^a   Roy, Denis ^a   Talajic, Mario ^a   Khairy, Paul ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Cardiac resynchronization therapy; Electric stimulation; Heart failure; Pacing

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; CARDIAC RESYNCHRONIZATION THERAPY; DOUBLE BLIND PROCEDURE; EXERCISE; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE PACING; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; QRS COMPLEX; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; REVIEW;

AGED; ARRHYTHMIAS, CARDIAC; CANADA; CARDIAC RESYNCHRONIZATION THERAPY; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; SYSTOLE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR FUNCTION, RIGHT;

EID: 84155165428     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.111.032904     Document Type: Review

References (44)

1. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary. Heart Rhythm. 2008;5:934-955.
2. Pfister R, Schneider CA. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: application of natriuretic peptides. Eur Heart J. 2009;30:382-383;author reply 383.
3. Abraham WT, Fisher WG, Smith AL, Delurgio DB, Leon AR, Loh E, Kocovic DZ, Packer M, Clavell AL, Hayes DL, Ellestad M, Trupp RJ, Underwood J, Pickering F, Truex C, McAtee P, Messenger J. Cardiac resynchronization in chronic heart failure. N Engl J Med. 2002;346: 1845-1853. (Pubitemid 34603028)
4. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L; Cardiac Resynchronization-Heart Failure (CARE-HF) Study. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549. (Pubitemid 40517094)
5. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med. 2009;361:1329-1338.
6. Daubert C, Gold MR, Abraham WT, Ghio S, Hassager C, Goode G, Szili-Torok T, Linde C. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial. J Am Coll Cardiol. 2009;54:1837-1846.
7. Tang AS, Wells GA, Talajic M, Arnold MO, Sheldon R, Connolly S, Hohnloser SH, Nichol G, Birnie DH, Sapp JL, Yee R, Healey JS, Rouleau JL. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med. 2010;363:2385-2395.
8. Boriani G, Muller CP, Seidl KH, Grove R, Vogt J, Danschel W, Schuchert A, Djiane P, Biffi M, Becker T, Bailleul C, Trappe HJ. Randomized comparison of simultaneous biventricular stimulation versus optimized interventricular delay in cardiac resynchronization therapy: the Resynchronization for the Hemodynamic Treatment for Heart Failure Management II Implantable Cardioverter Defibrillator (RHYTHM II CD) study. Am Heart J. 2006;151:1050-1058.
9. Bertini M, Ziacchi M, Biffi M, Martignani C, Saporito D, Valzania C, Diemberger I, Cervi E, Frisoni J, Sangiorgi D, Branzi A, Boriani G. Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width. Am J Cardiol. 2008;102:1373-1377.
10. Abraham WT, Gras D, Yu CM, Guzzo L, Gupta MS. Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: the Frequent Optimization Study Using the QuickOpt Method (FREEDOM) trial. Am Heart J. 2010;159:944-948.
11. Thibault B, Shi HY, Ducharme A, Deblasio E, Guerra P, Macle L, Talajic M, Roy D, Dubuc M, Tardif JC. Differential effects of RV vs. BiV vs. LV stimulation on the systolic function of the left and right ventricles: hemodynamic-echocardiolographic correlations in the canine model of heart failure induced by rapid pacing. Heart Rhythm. 2004;1:785.
12. Leclercq C, Faris O, Tunin R, Johnson J, Kato R, Evans F, Spinelli J, Halperin H, McVeigh E, Kass DA. Systolic improvement and mechanical resynchronization does not require electrical synchrony in the dilated failing heart with left bundle-branch block. Circulation. 2002;106: 1760-1763.
13. Etienne Y, Mansourati J, Touiza A, Gilard M, Bertault-Valls V, Guillo P, Boschat J, Blanc JJ. Evaluation of left ventricular function and mitral regurgitation during left ventricular-based pacing in patients with heart failure. Eur J Heart Fail. 2001;3:441-447. (Pubitemid 32776871)
14. Touiza A, Etienne Y, Gilard M, Fatemi M, Mansourati J, Blanc JJ. Long-term left ventricular pacing: assessment and comparison with biventricular pacing in patients with severe congestive heart failure. J Am Coll Cardiol. 2001;38:1966-1970. (Pubitemid 33116571)
15. Blanc JJ, Bertault-Valls V, Fatemi M, Gilard M, Pennec PY, Etienne Y. Midterm benefits of left univentricular pacing in patients with congestive heart failure. Circulation. 2004;109:1741-1744. (Pubitemid 38500676)
16. Bordachar P, Garrigue S, Reuter S, Hocini M, Kobeissi A, Gaggini G, Jais P, Haissaguerre M, Clementy J. Hemodynamic assessment of right, left, and biventricular pacing by peak endocardial acceleration and echocardiography in patients with end-stage heart failure. Pacing Clin Electrophysiol. 2000;23:1726-1730.
17. Brignole M, Gammage M, Puggioni E, Alboni P, Raviele A, Sutton R, Vardas P, Bongiorni MG, Bergfeldt L, Menozzi C, Musso G. Comparative assessment of right, left, and biventricular pacing in patients with permanent atrial fibrillation. Eur Heart J. 2005;26:712-722. (Pubitemid 40516884)
18. Puggioni E, Brignole M, Gammage M, Soldati E, Bongiorni MG, Simantirakis EN, Vardas P, Gadler F, Bergfeldt L, Tomasi C, Musso G, Gasparini G, Del Rosso A. Acute comparative effect of right and left ventricular pacing in patients with permanent atrial fibrillation. J Am Coll Cardiol. 2004;43:234-238. (Pubitemid 38201149)
19. Rao RK, Kumar UN, Schafer J, Viloria E, De Lurgio D, Foster E. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation. 2007;115:2136-2144. (Pubitemid 46659065)
20. Gasparini M, Bocchiardo M, Lunati M, Ravazzi PA, Santini M, Zardini M, Signorelli S, Passardi M, Klersy C. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle-branch block: the Bi vs Left Ventricular Pacing: An International Pilot Evaluation on Heart Failure Patients With Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J. 2006;152:155.e1-155.e7.
21. Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, Lozano IF, Ansalone G, Biffi M, Boulogne E, Leclercq C. A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular Versus Left Univentricular Pacing With ICD Back-up in Heart Failure Patients (B-LEFT HF) trial. Am Heart J. 2010;159:1052-1058.
22. Olsson LG, Swedberg K, Clark AL, Witte KK, Cleland JG. Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review. Eur Heart J. 2005;26:778-793. (Pubitemid 40547080)
23. Thibault B, Harel F, Ducharme A, White M, Frasure-Smith N, Roy D, Philippon F, Dorian P, Talajic M, Dubuc M, Gagné P, Guerra PG, Macle L, Rivard L, Khairy P. Evaluation of Resynchronization Therapy for Heart Failure in Patients With a QRS Duration Greater Than 120 ms (GREATER-EARTH) trial: rationale, design, and baseline characteristics [published online ahead of print July 24, 2011]. Can J Cardiol. doi: 10.1016/j.cjca.2011.03.010.
24. Garin O, Ferrer M, Pont A, Rue M, Kotzeva A, Wiklund I, Van Ganse E, Alonso J. Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses. Qual Life Res. 2009;18:71-85.
25. Blanchet M, Ducharme A, Racine N, Rouleau JL, Tardif JC, Juneau M, Marquis J, Larivee L, Nigam A, Fortier A, White M. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol). Am J Cardiol. 2003;92:548-553. (Pubitemid 37013407)
26. Metra M, Nodari S, Raccagni D, Garbellini M, Boldi E, Bontempi L, Gaiti M, Dei Cas L. Maximal and submaximal exercise testing in heart failure. J Cardiovasc Pharmacol. 1998;32(suppl 1):S36-S45. (Pubitemid 28415090)
27. Johnson MJ, Oxberry SG, Cleland JG, Clark AL. Measurement of breathlessness in clinical trials in patients with chronic heart failure: the need for a standardized approach: a systematic review. Eur J Heart Fail. 2010; 12:137-147.
28. Fornwalt BK, Sprague WW, BeDell P, Suever JD, Gerritse B, Merlino JD, Fyfe DA, Leon AR, Oshinski JN. Agreement is poor among current criteria used to define response to cardiac resynchronization therapy. Circulation. 2010;121:1985-1991.
29. Senn S. The AB/BA design with normal data. In: Senn S, ed. Cross-over Trials in Clinical Research. West Sussex, England: John Wiley & Sons, Ltd; 2002;35-54.
30. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119:256-270. (Pubitemid 32150576)
31. Hamilton DM, Haennel RG. Validity and reliability of the 6-minute walk test in a cardiac rehabilitation population. J Cardiopulm Rehabil. 2000; 20:156-164. (Pubitemid 30368508)
32. Boutron I, Dutton S, Ravaud P, Altman DG. Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA. 2010;303:2058-2064.
33. Cohn J, Cleland JG, Lubsen J, Borer JS, Steg PG, Perelman M, Zannad F. Unconventional end points in cardiovascular clinical trials: should we be moving away from morbidity and mortality? J Card Fail. 2009;15: 199-205.
34. Packer M. Proposal for a new clinical end point to evaluate the efficacy of drugs and devices in the treatment of chronic heart failure. J Card Fail. 2001;7:176-182. (Pubitemid 32554111)
35. Opasich C, Pinna GD, Mazza A, Febo O, Riccardi R, Riccardi PG, Capomolla S, Forni G, Cobelli F, Tavazzi L. Six-minute walking performance in patients with moderate-to-severe heart failure; is it a useful indicator in clinical practice? Eur Heart J. 2001;22:488-496. (Pubitemid 32619622)
36. Jehn M, Halle M, Schuster T, Hanssen H, Weis M, Koehler F, Schmidt-Trucksass A. The 6-min walk test in heart failure: is it a max or submaximum exercise test? Eur J Appl Physiol. 2009;107:317-323.
37. Clark AL, Cleland JG. How do you measure exercise capacity in chronic heart failure? Eur Heart J. 2001;22:627-628. (Pubitemid 32622422)
38. Weber KT, Janicki JS. Cardiopulmonary Exercise Testing: Physiologic Principles and Clinical Applications. Philadelphia, PA: WB Saunders Co; 1986.
39. Goda A, Lang CC, Williams P, Jones M, Farr MJ, Mancini DM. Usefulness of non-invasive measurement of cardiac output during submaximal exercise to predict outcome in patients with chronic heart failure. Am J Cardiol. 2009;104:1556-1560.
40. Williams SG, Jackson M, Ng LL, Barker D, Patwala A, Tan LB. Exercise duration and peak systolic blood pressure are predictive of mortality in ambulatory patients with mild-moderate chronic heart failure. Cardiology. 2005;104:221-226. (Pubitemid 41407279)
41. Larsen AI, Aarsland T, Kristiansen M, Haugland A, Dickstein K. Assessing the effect of exercise training in men with heart failure; comparison of maximal, submaximal and endurance exercise protocols. Eur Heart J. 2001;22:684-692. (Pubitemid 32622429)
42. Miyazaki C, Redfield MM, Powell BD, Lin GM, Herges RM, Hodge DO, Olson LJ, Hayes DL, Espinosa RE, Rea RF, Bruce CJ, Nelson SM, Miller FA, Oh JK. Dyssynchrony indices to predict response to cardiac resynchronization therapy: a comprehensive prospective single-center study. Circ Heart Fail. 2010;3:565-573.
43. Birnie DH, Tang AS. The problem of non-response to cardiac resynchronization therapy. Curr Opin Cardiol. 2006;21:20-26. (Pubitemid 43194328)
44. Poole JE, Gleva MJ, Mela T, Chung MK, Uslan DZ, Borge R, Gottipaty V, Shinn T, Dan D, Feldman LA, Seide H, Winston SA, Gallagher JJ, Langberg JJ, Mitchell K, Holcomb R. Complication rates associated with pacemaker or implantable cardioverter-defibrillator generator replacements and upgrade procedures: results from the REPLACE Registry. Circulation. 2010;122:1553-1561.